Ethicon, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ethicon, Inc. - overview
Established
1992
Location
Cincinnati, OH, US
Primary Industry
Medical Devices & Equipment
About
Ethicon, Inc. is a medical device company specializing in surgical solutions aimed at improving patient care and outcomes through innovative technology and advanced surgical techniques. Ethicon, Inc. was founded in 1992 in Cincinnati, US, as a subsidiary of Johnson & Johnson MedTech.
The company focuses on delivering surgical technologies that enhance procedural efficiency and patient outcomes. The current CEO is Benjamin Manico. Ethicon Surgical Technologies, part of Johnson & Johnson MedTech, specializes in creating innovative surgical solutions aimed at enhancing patient care through tailored approaches. The company's core product offerings include the ENSEAL™ X1 Tissue Sealers, MONARCH™ Robotic Platform, and NeuWave™ Microwave Ablation System.
These products are designed to meet the diverse needs of healthcare professionals by providing advanced surgical techniques that encompass open surgery, laparoscopic, endoluminal, and percutaneous procedures. The ENSEAL™ X1, for instance, delivers efficient and secure tissue sealing, while the MONARCH™ platform facilitates bronchoscopic visualization and access for diagnostic and therapeutic procedures. Ethicon's solutions target pressing health challenges such as metabolic diseases, cardiovascular conditions, and cancer, serving a global client base that includes hospitals, surgical centers, and healthcare professionals across North America, Europe, and Asia-Pacific regions. Ethicon Surgical Technologies generates revenue through direct sales of its surgical products to healthcare institutions and professionals, leveraging a B2B transactional model.
Sales typically occur via established distribution channels, where healthcare providers purchase products such as the ENSEAL™ X1 Tissue Sealers and MONARCH™ Robotic Platform directly. The company may engage in partnerships and collaborations with hospitals for product trials and training, enhancing client relationships and driving product adoption. Transactions are structured around bulk orders and may include service agreements for ongoing support and training, ensuring that healthcare providers are equipped with the necessary tools and knowledge to utilize Ethicon's advanced surgical technologies effectively. The company's revenue stream is bolstered by its comprehensive customer support services, which provide 24/7 assistance to clients.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.ethicon.com
Total Amount Raised
Subscriber access only
Ethicon, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | SterilMed | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.